House Bill 3570
116th Congress(2019-2020)
Therapeutic Fraud Prevention Act of 2019
Introduced
Introduced in House on Jun 27, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3570
Congress
116
Policy Area
Commerce
Commerce
Primary focus of measure is business investment, development, regulation; small business; consumer affairs; competition and restrictive trade practices; manufacturing, distribution, retail; marketing; intellectual property. Measures concerning international competitiveness and restrictions on imports and exports may fall under Foreign Trade and International Finance policy area.
Ted Lieu
grade
California
Alabama
Arizona
Arizona
Arizona
Arizona
Arizona
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
Colorado
Colorado
Colorado
Colorado
Connecticut
Connecticut
Connecticut
Connecticut
Connecticut
Delaware
District of Columbia
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Georgia
Georgia
Georgia
Hawaii
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Indiana
Iowa
Iowa
Iowa
Kansas
Kentucky
Louisiana
Maine
Maine
Maryland
Maryland
Maryland
Maryland
Maryland
Maryland
Maryland
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Michigan
Michigan
Michigan
Michigan
Michigan
Michigan
Michigan
Minnesota
Minnesota
Minnesota
Minnesota
Mississippi
Missouri
Missouri
Nevada
Nevada
Nevada
New Hampshire
New Hampshire
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Mexico
New Mexico
New Mexico
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
North Carolina
North Carolina
Ohio
Ohio
Ohio
Ohio
Oregon
Oregon
Oregon
Oregon
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Rhode Island
Rhode Island
South Carolina
Tennessee
Tennessee
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Vermont
Virginia
Virginia
Virginia
Virginia
Virginia
Virginia
Washington
Washington
Washington
Washington
Washington
Washington
Washington
Wisconsin
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
Therapeutic Fraud Prevention Act of 2019
This bill prohibits commercial conversion therapy, which is a practice or treatment designed to change a person's sexual orientation or gender identity or otherwise change behaviors, thoughts, or expressions related to gender or sexual attraction. This prohibition does not apply to treatment that assists an individual undergoing a gender transition or facilitates identity exploration and development.
June 27, 2019
06/28/2019
Referred to the Subcommittee on Consumer Protection and Commerce.
06/27/2019
Referred to the House Committee on Energy and Commerce.
06/27/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:50:49 PM